Trial Profile
An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Administered in Korean Diabetic Patients According to the Prescribing Information.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Rosiglitazone/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms AVANDAMET PMS
- Sponsors GSK
- 18 Feb 2011 New trial record